Mehra Anand insider trades
Mehra Anand has filed 12 Form 4s with the SEC that we hold, for Aclaris Therapeutics, Inc. (ACRS) (Director) and MRUS (Director). Across all of them we count 1 purchase worth $1.5M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 666,666 shares of Aclaris Therapeutics, Inc. worth $1.5M, dated 2024-11-19. The first filing on our record is dated 2022-06-02 and the latest 2026-06-08.
Aclaris Therapeutics, Inc. (ACRS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-11-19 | P, purchase reported on Form 4 | 666,666 | $1.5M | 2024-11-20 |
MRUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1590102) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms